Jackson Square Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$1.25B |
| 2 |
MASI
Masimo
MASI
|
+$85.6M |
| 3 |
MarketAxess Holdings
MKTX
|
+$38.4M |
| 4 |
STAAR Surgical
STAA
|
+$33.4M |
| 5 |
HAPN
Happen Inc
HAPN
|
+$37.7K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$66.2M |
| 2 |
Papa John's
PZZA
|
+$55.6M |
| 3 |
New York Times
NYT
|
+$46.5M |
| 4 |
Lattice Semiconductor
LSCC
|
+$34.2M |
| 5 |
Elastic
ESTC
|
+$29.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Industrials | 22.77% |
| 3 | Healthcare | 17.06% |
| 4 | Financials | 11.38% |
| 5 | Communication Services | 11.11% |
Similar funds
Jackson Square Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Jackson Square Partners held 86 positions worth $2.99B, down 13% from $3.43B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Jackson Square Partners deployed $945M of net new capital in Q3 2023, opening 1 new position and adding to 6 existing holdings. Its largest new stake was Synopsys: 2,793,078 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Charles River Laboratories, an estimated $66.2M trimmed.
- Jackson Square Partners's largest Q3 2023 buy was Synopsys: 2,793,078 shares worth $49.4M.
- Jackson Square Partners added most to Masimo in Q3 2023, an estimated $85.6M increase.
- Jackson Square Partners's biggest Q3 2023 reduction was Charles River Laboratories, cutting an estimated $66.2M.
- Jackson Square Partners fully exited Papa John's in Q3 2023, selling an estimated $55.6M.
- Jackson Square Partners's ten largest holdings make up 43% of its $2.99B portfolio in Q3 2023.
- Jackson Square Partners opened 1 new position and closed 1 in Q3 2023.
- Jackson Square Partners's portfolio value fell 13% quarter-over-quarter to $2.99B.
Based on Jackson Square Partners's 13F filing for Q3 2023, filed 13 Nov 2023.